Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "CCI"

1207 News Found

ZyCoV-D to be initially administered in seven states
News | December 02, 2021

ZyCoV-D to be initially administered in seven states

The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20


Covishield effectiveness during the second wave at 63 per cent
Public Health | November 30, 2021

Covishield effectiveness during the second wave at 63 per cent

Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent


Govt reviews public health preparedness with states/UTs over Omicron
Policy | November 30, 2021

Govt reviews public health preparedness with states/UTs over Omicron

The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases


Bharat Biotech commences export of Covaxin
News | November 29, 2021

Bharat Biotech commences export of Covaxin

It’s a two-dose vaccine administered 28 days apart


Thermo Fisher Scientific confirms its TaqParth Covid-19 kit can detect Omicron
Medical Device | November 29, 2021

Thermo Fisher Scientific confirms its TaqParth Covid-19 kit can detect Omicron

The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone


Pharma firms switch to advanced pharma manufacturing
Supply Chain | November 27, 2021

Pharma firms switch to advanced pharma manufacturing

Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies


Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron
Biotech | November 26, 2021

Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron

The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease


Sputnik Light in India by December: RDIF
News | November 25, 2021

Sputnik Light in India by December: RDIF

One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster


Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D
News | November 25, 2021

Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D

The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022


Bharat Biotech updates on the Lancet study on Covaxin efficacy
News | November 25, 2021

Bharat Biotech updates on the Lancet study on Covaxin efficacy

An effectiveness result of 50 per cent achieved during the peak delta variant Covid-19 wave in India, in a highrisk study population of physicians and healthcare workers, in a hospital environment, provides insights into the efficacy and effectiveness of Covaxin